Corebridge Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-564,199
Closed -$50.6M 1709
2025
Q1
$50.6M Sell
564,199
-17,190
-3% -$1.6M 0.29% 45
2024
Q4
$57.8M Sell
581,389
-35,685
-6% -$3.68M 0.31% 37
2024
Q3
$70.1M Sell
617,074
-19,091
-3% -$2.27M 0.37% 32
2024
Q2
$78.8M Buy
+636,165
New +$81.9M 0.43% 24

Other funds holding MRK

Corebridge Financial's MRK Position: Q2 2025 in Review

Corebridge Financial sold out of Merck (MRK) in Q2 2025, closing a stake of 564,199 shares — an estimated $50.6M sold.

Corebridge Financial first reported a position in MRK in Q2 2024 and held it in 4 quarters. The position peaked at $78.8M in Q2 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Corebridge Financial reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 564,199 Merck shares in Q2 2025, an estimated $50.6M.
  • Corebridge Financial first reported a position in Merck in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Merck position peaked at $78.8M in Q2 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.